GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avant Brands Inc (TSX:AVNT) » Definitions » EV-to-EBITDA

Avant Brands (TSX:AVNT) EV-to-EBITDA : 16.18 (As of May. 29, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Avant Brands EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Avant Brands's enterprise value is C$36.03 Mil. Avant Brands's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 was C$2.23 Mil. Therefore, Avant Brands's EV-to-EBITDA for today is 16.18.

The historical rank and industry rank for Avant Brands's EV-to-EBITDA or its related term are showing as below:

TSX:AVNT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -70.77   Med: -4.65   Max: 21.32
Current: 16.18

During the past 12 years, the highest EV-to-EBITDA of Avant Brands was 21.32. The lowest was -70.77. And the median was -4.65.

TSX:AVNT's EV-to-EBITDA is ranked worse than
55.94% of 715 companies
in the Drug Manufacturers industry
Industry Median: 14.5 vs TSX:AVNT: 16.18

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-29), Avant Brands's stock price is C$0.07. Avant Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$-0.024. Therefore, Avant Brands's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Avant Brands EV-to-EBITDA Historical Data

The historical data trend for Avant Brands's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avant Brands EV-to-EBITDA Chart

Avant Brands Annual Data
Trend Dec14 Dec15 Dec16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.48 -4.59 -4.36 -21.58 11.57

Avant Brands Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -79.78 14.50 19.22 11.57 21.82

Competitive Comparison of Avant Brands's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Avant Brands's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Avant Brands's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Avant Brands's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Avant Brands's EV-to-EBITDA falls into.



Avant Brands EV-to-EBITDA Calculation

Avant Brands's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=36.027/2.226
=16.18

Avant Brands's current Enterprise Value is C$36.03 Mil.
Avant Brands's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Avant Brands  (TSX:AVNT) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Avant Brands's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.07/-0.024
=At Loss

Avant Brands's share price for today is C$0.07.
Avant Brands's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.024.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Avant Brands EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Avant Brands's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Avant Brands (TSX:AVNT) Business Description

Traded in Other Exchanges
Address
1632 Dickson Avenue, Suite 335, Kelowna, BC, CAN, V1Y 7T2
Avant Brands Inc is an innovative premium cannabis company. It has multiple licensed and operational production facilities across Canada, which produce high-quality, handcrafted cannabis products for highly desired, and award-winning consumer brands, sold across both recreational and medical channels.
Executives
Norton Singhavon 10% Security Holder, Director, Senior Officer

Avant Brands (TSX:AVNT) Headlines